The Latest Breaking News from Medicaid

Long-term care insurance can be a financial lifeline for older adults who want to protect their savings from the crushing costs of nursing homes, assisted...

A federal appeals court has revived a proposed class action accusing four major drugmakers of conspiring to restrict a government-mandated drug discount program, allegedly driving up costs for safety-net hospitals and clinics serving low-income patients.

President Donald Trump signed the One Big Beautiful Bill Act into law on July 4, a policy that tightened Medicaid requirements for 80 million Americans and accelerated expansion plans for a little-known AI-powered healthcare startup that just secured $18 million in a Series A funding round led by Andreessen Horowitz…

Adding your child’s name to your house title sounds simple. Many parents think it’s a way to help their kids or avoid future problems. But...

Republicans see it as the epitome of Trump keeping his promises, while for Democrats it’s an opportunity to return from the political wilderness

For many seniors, Medicaid can be a financial lifeline, covering medical expenses, long-term care, and services that private insurance or Medicare won’t. But qualifying for...

Renovation grants sound like a win-win. You improve your home with financial assistance, and your quality of life increases. But some renovation grants come with hidden strings—conditions that can delay estate transfers, reduce inheritance value, or trigger unexpected taxes. For families trying to build generational wealth or leave property behind…

Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif threats.

A trust can look like a neat shortcut to protect assets and make heirs’ lives easier. But some trusts carry hidden limits or trade-offs that hurt more than help. Knowing which vehicles are actually risky trusts lets you avoid bad surprises. Read these eight types and learn simple steps to…

AbbVie Inc. (NYSE:ABBV), the manufacturer of Imbruvica, is at the center of a constitutional challenge to the federal government's new Drug Price Negotiation Program.

For many people, the idea of passing down wealth, property, or cherished family possessions is as much about legacy as it is about money. But...